SEC Form 4 · accession 0001493152-17-014767
Medovex Corp. · MDVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
John C Thomas
Director
Period of report
Dec 15, 2017
Accepted (ET)
Dec 19, 2017 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001591165
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 15, 2017 | P | 6,000 | $0.70 | D | 115,960 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares purchased trade publicly under the symbol "MDVX" on the OTCQB Tier of the OTC Markets, Inc.